Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,421,334 shares of BIO stock, worth $661 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,421,334
Previous 2,389,889
1.32%
Holding current value
$661 Million
Previous $772 Million
8.53%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding BIO
# of Institutions
489Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Black Rock Inc. New York, NY1.48MShares$404 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$313 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$239 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$141 Million0.84% of portfolio
-
Select Equity Group, L.P. New York, NY515KShares$141 Million0.66% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.73B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...